Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000935069-05-001710
Filing Date
2005-06-21
Accepted
2005-06-21 09:20:22
Documents
1

Document Format Files

Seq Description Document Type Size
1 GALLEON SAVIENT PHARMACEUTICALS SC 13G/A g18376galleon_savientpharm.txt SC 13G/A 43410
  Complete submission text file 0000935069-05-001710.txt   45658
Mailing Address ONE TOWER CENTER EAST BRUNSWICK NJ 08816
Business Address ONE TOWER CENTER EAST BRUNSWICK NJ 08816 7324189300
SAVIENT PHARMACEUTICALS INC (Subject) CIK: 0000722104 (see all company filings)

EIN.: 133033811 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-34455 | Film No.: 05907041
SIC: 2833 Medicinal Chemicals & Botanical Products

Mailing Address 135 EAST 57TH STREET 16TH FLOOR 16TH FLOOR NEW YORK NY 10022
Business Address 135 E 57TH STREET 16TH FLOOR NEW YORK NY 10022 212-371-2939
GALLEON MANAGEMENT L P (Filed by) CIK: 0001056829 (see all company filings)

EIN.: 133926982 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A